Raymond James Financial Services Advisors’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$578K Sell
2022
Q4
$550K Buy
2022
Q3
$480K Hold
2022
Q2
$481K Buy
2022
Q1
$533K Buy
2021
Q4
$486K Buy